Tuesday, Aug 04, 2020 | Last Update : 10:43 PM IST

133rd Day Of Lockdown

Maharashtra45019628703015842 Tamil Nadu2632222022834241 Andhra Pradesh166586886781537 Karnataka139571625002594 Delhi1384821242544021 Uttar Pradesh97362553931778 West Bengal78232548181731 Telangana6766048609551 Gujarat64684476632504 Bihar5956738508336 Rajasthan4555532051719 Assam4527633429109 Haryana3717330470440 Odisha3629723074248 Madhya Pradesh3428524099900 Kerala268731527885 Jammu and Kashmir2200614032407 Punjab1852711882442 Jharkhand135004794125 Chhatisgarh9820725661 Uttarakhand7800453890 Goa6816487656 Tripura5389360527 Puducherry3982241156 Manipur292017667 Himachal Pradesh2818165813 Nagaland21296574 Arunachal Pradesh175810633 Chandigarh116070619 Meghalaya9022645 Sikkim6882971 Mizoram4962660
  Life   Health  17 Jun 2018  Obesity, smoking may hinder arthritis treatment: Study

Obesity, smoking may hinder arthritis treatment: Study

REUTERS
Published : Jun 17, 2018, 12:09 pm IST
Updated : Jun 17, 2018, 12:09 pm IST

Lifestyle changes as well as optimising methotrexate use may facilitate rapid reduction of inflammation.

Representational Image. (Photo: Pixabay)
 Representational Image. (Photo: Pixabay)

Obesity in women and smoking in men can hinder the treatment of rheumatoid arthritis, a study has found.

Although early identification and aggressive treatment of rheumatoid arthritis (RA) improves outcomes, this study showed that 46 per cent of women and 38 per cent of men did not achieve remission in the first year despite receiving guideline-based care.

 

Multivariable analysis highlighted that obesity more than doubled the likelihood of not achieving remission in women.

Other predictors were minority status, lower education, higher tender joint counts and fatigue scores at baseline. In men, current smoking was associated with 3.5 greater odds of not achieving remission within the first year. Other predictors included older age and higher pain.

Almost all patients within the study were initially treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with three quarters being treated with methotrexate.

Analysis demonstrated that not using methotrexate significantly increased the likelihood of not achieving remission in women by 28 per cent and men by 45 per cent.

 

"Our results suggest that lifestyle changes - smoking cessation in men and weight reduction in women - as well as optimising methotrexate use may facilitate rapid reduction of inflammation, an essential goal of treatment in early rheumatoid arthritis," said Susan J Bartlett, professor at McGill University in Canada.

The study included 1,628 adults with early RA enrolled in the Canadian Early Arthritis Cohort (2007-16) and receiving guideline-based care.

Baseline sociodemographic and RA characteristics and patient reported outcomes over 12 months were used to identify predictors of failing to achieve remission.

Participants were mostly female (72 per cent) with an average age of 55. They had an average of two comorbidities, and symptom duration of six months.

 

Tags: obesity, smoking, arthritis, health, rheumatoid arthritis (ra), drugs